VIOLIN Logo
VO Banner
Search: for Help
About
Introduction
Statistics
VIOLIN News
Your VIOLIN
Register or Login
Submission
Tutorial
Vaccine & Components
Vaxquery
Vaxgen
VBLAST
Protegen
VirmugenDB
DNAVaxDB
CanVaxKB
Vaxjo
Vaxvec
Vevax
Huvax
Cov19VaxKB
VaxCT
Host Responses
VaximmutorDB
VIGET
Vaxafe
Vaxar
Vaxism
Vaccine Literature
VO-SciMiner
Litesearch
Vaxmesh
Vaxlert
Vaccine Design
Vaxign2
Vaxign
Community Efforts
Vaccine Ontology
ICoVax 2012
ICoVax 2013
Advisory Committee
Vaccine Society
Vaxperts
VaxPub
VaxCom
VaxLaw
VaxMedia
VaxMeet
VaxFund
VaxCareer
Data Exchange
V-Utilities
VIOLINML
Help & Documents
Publications
Documents
FAQs
Links
Acknowledgements
Disclaimer
Contact Us
UM Logo

Pathogen Page
Cancer

Table of Contents

  1. General Information
    1. Disease
    2. Introduction
  2. Vaccine Related Pathogen Genes
    1. 7299
    2. AAV2gp02 (Adeno-associated virus - 2)
    3. ABALON (Homo sapiens)
    4. ABL2 (Homo sapiens)
    5. ACP3 (Homo sapiens)
    6. ACPP (Homo sapiens)
    7. ADAM17 (Homo sapiens)
    8. AFP (Homo sapiens)
    9. AFP from human-Obsolete (Homo sapiens)
    10. ag85A (Mycobacterium tuberculosis H37Rv)
    11. AIM2 (Homo sapiens)
    12. AKAP4 (Homo sapiens)
    13. AKT1 (Homo sapiens)
    14. ALDH1A1 (Homo sapiens)
    15. ALDH2 (Homo sapiens)
    16. ANTXR1 (Homo sapiens)
    17. AR (Homo sapiens)
    18. asdfaf asf
    19. ASTE1 (Homo sapiens)
    20. ATL1 (Homo sapiens)
    21. B4GALNT1 (Homo sapiens)
    22. BCAP31 (Homo sapiens)
    23. BCL2L1 (Homo sapiens)
    24. CA9 (Homo sapiens)
    25. CCL21 (Homo sapiens)
    26. Ccl21a (Mus musculus)
    27. CCNG1 (Homo sapiens)
    28. CCNI (Homo sapiens)
    29. CCR5 (Homo sapiens)
    30. CCR7 (Homo sapiens)
    31. CD19 (Homo sapiens)
    32. CD1D (Homo sapiens)
    33. CD22 (Homo sapiens)
    34. CD33 (Homo sapiens)
    35. CD38 (Homo sapiens)
    36. CD3D (Homo sapiens)
    37. CD40 (Homo sapiens)
    38. Cd40lg (Mus musculus)
    39. CD40LG (Homo sapiens)
    40. CD44 (Homo sapiens)
    41. CD55 (Homo sapiens)
    42. CD58 (Homo sapiens)
    43. CD70 (Homo sapiens)
    44. Cd80 (Mus musculus)
    45. CD80 (Homo sapiens)
    46. Cd86 (Mus musculus)
    47. CD86 (Homo sapiens)
    48. CD8A (Homo sapiens)
    49. CD90 (Homo sapiens)
    50. CDH3 (Homo sapiens)
    51. CDK1 (Homo sapiens)
    52. cdsR (Chlamydia trachomatis A/HAR-13)
    53. Cea-Mouse (Mus musculus)
    54. CEACAM1 (Homo sapiens)
    55. CEACAM3 (Homo sapiens)
    56. CEACAM5 (CEA) (Homo sapiens)
    57. CEACAM5 - obsolete (Homo sapiens)
    58. CHI3L1 (Homo sapiens)
    59. CLEC3B (Homo sapiens)
    60. CLEC4C (Homo sapiens)
    61. CRY2 (Arabidopsis thaliana)
    62. CSF1R (Homo sapiens)
    63. Csf2-Mouse (Mus musculus)
    64. CSH1 (Homo sapiens)
    65. CTAG1B (Homo sapiens)
    66. CTAG2 (Homo sapiens)
    67. CTLA4 (Homo sapiens)
    68. cupB5 (Pseudomonas aeruginosa PAO1)
    69. CYP1B1 (Homo sapiens)
    70. DCT (Homo sapiens)
    71. DCT (Homo sapiens)
    72. DDR1 (Homo sapiens)
    73. DEPDC1 (Homo sapiens)
    74. DItox
    75. E1B (Human mastadenovirus C)
    76. E2A (Mus musculus)
    77. E6 (Human papillomavirus type 16)
    78. E7 (Human papillomavirus type 16)
    79. EBNA-1 (Human gammaherpesvirus 4)
    80. EGFR (Homo sapiens)
    81. Emb (Mus musculus)
    82. Eng (Mus musculus)
    83. ENG (Homo sapiens)
    84. env (Human immunodeficiency virus 1)
    85. EPCAM (Homo sapiens)
    86. EPHA2 (Homo sapiens)
    87. ERBB2 (Homo sapiens)
    88. Erbb2 (Rattus norvegicus)
    89. EWSR1 (Homo sapiens)
    90. Fasl (Mus musculus)
    91. FASLG (Homo sapiens)
    92. FCY1 (Saccharomyces cerevisiae S288C)
    93. FGF2 (Homo sapiens)
    94. FGF5 (Homo sapiens)
    95. FIM3 (Homo sapiens)
    96. FL1 (Homo sapiens)
    97. FLT1 (Homo sapiens)
    98. Flt3 (Mus musculus)
    99. FLT3LG (Homo sapiens)
    100. FOLH1 (Homo sapiens)
    101. FOLR1 (Homo sapiens)
    102. Fosl1 (Mus musculus)
    103. FOXO1 (Homo sapiens)
    104. Fragment C from tetanus toxin (Clostridium tetani)
    105. FUS (Homo sapiens)
    106. GAA (Homo sapiens)
    107. GALC (Homo sapiens)
    108. Gla (Mus musculus)
    109. GLIPR1 (Homo sapiens)
    110. GM-CSF (Papio anubis)
    111. GM-CSF (human) (Homo sapiens)
    112. GM-CSF (Mus musculus) (Mus musculus)
    113. GM2A (Homo sapiens)
    114. GNRH1 (Homo sapiens)
    115. Gnrh1 (Mus musculus)
    116. gp100 (PMEL) (Homo sapiens)
    117. gp160
    118. gp72 (Human herpesvirus 4 type 2)
    119. GPC3 (Homo sapiens)
    120. GPR183 (Homo sapiens)
    121. GPT (Homo sapiens)
    122. GRDX (Homo sapiens)
    123. GRIN1 (Homo sapiens)
    124. GRP (Homo sapiens)
    125. GUCY2C (Homo sapiens)
    126. H2-K1 (Mus musculus)
    127. HA (Influenza A virus (A/California/07/2009(H1N1)))
    128. HBB (Homo sapiens)
    129. HBsAg (Hepatitis B virus)
    130. HER2-Dupli
    131. HLA-A (Homo sapiens)
    132. HLA-B (Homo sapiens)
    133. HLA-DRB1 (Homo sapiens)
    134. HPV6 E6 (Human papillomavirus type 6)
    135. HPV6 E6 (Human papillomavirus type 6)
    136. HRAS (Homo sapiens)
    137. HSP47 (Mus musculus)
    138. HSP90B1 (Homo sapiens)
    139. HSPA4 (Homo sapiens)
    140. HSPD1 (Homo sapiens)
    141. HuD (Homo sapiens)
    142. human TP53 (P53) (Homo sapiens)
    143. HUMGP 75 (Homo sapiens)
    144. ICAM1 (Homo sapiens)
    145. ID1 (Homo sapiens)
    146. IDH1 (Homo sapiens)
    147. IDO1 (Homo sapiens)
    148. IFNA2 (Homo sapiens)
    149. IFNB1 (Homo sapiens)
    150. IFNG (Homo sapiens)
    151. IFNG- Obsolete (Homo sapiens)
    152. IFNL3 (Homo sapiens)
    153. IGF2BP3 (Homo sapiens)
    154. IGFBP1 (Homo sapiens)
    155. IgG Fc (Homo sapiens)
    156. IGHG1 (Homo sapiens)
    157. IL12 (Sus scrofa)
    158. IL12A (Homo sapiens)
    159. IL12B (Homo sapiens)
    160. IL13RA2 (Homo sapiens)
    161. Il18 (Mus musculus)
    162. IL2 (Homo sapiens)
    163. IL2-Duplicate (Homo sapiens)
    164. IL24 (Homo sapiens)
    165. IL3RA (Homo sapiens)
    166. Immunoglobulin (Homo sapiens)
    167. ITGB8 (Homo sapiens)
    168. ITIH4 (Homo sapiens)
    169. JUP (Homo sapiens)
    170. KDR (Homo sapiens)
    171. Kdr (Mus musculus)
    172. KIF20B (Homo sapiens)
    173. KLK3 (Homo sapiens)
    174. KLK3-Dupli (Homo sapiens)
    175. KRAS (Homo sapiens)
    176. KRAS (Homo sapiens)
    177. L1 (Human papillomavirus)
    178. lacZ (Escherichia coli str. K-12 substr. MG1655)
    179. LADD-Ag
    180. LILRA2 (Homo sapiens)
    181. LMP-1 (Human gammaherpesvirus 4)
    182. LMP-2A (Human gammaherpesvirus 4)
    183. LV28_RS26095 transcriptional regulator RegF (Pandoraea pnomenusa)
    184. LY6K (Homo sapiens)
    185. MAGE-1 (Homo sapiens)
    186. MAGEA1 (MAGE1) (Homo sapiens)
    187. MAGEA1-Duplicate
    188. MAGEA10 (Homo sapiens)
    189. MAGEA2 (Homo sapiens)
    190. MAGEA3 (Homo sapiens)
    191. MAGEA6 (Homo sapiens)
    192. MAGEA9 (Homo sapiens)
    193. MAGEC1 (Homo sapiens)
    194. MAGEC2 (Homo sapiens)
    195. major capsid protein L1
    196. MBL2 (Homo sapiens)
    197. Mcam (Mus musculus)
    198. MDM2 (Homo sapiens)
    199. MFGE8 (Homo sapiens)
    200. MGMT (Homo sapiens)
    201. Mice Gene
    202. MLANA (Homo sapiens)
    203. MLANA-Dupli (Homo sapiens)
    204. mouse Trp53 (Mus musculus)
    205. MOV10 (Homo sapiens)
    206. MS4A1 (Homo sapiens)
    207. MSLN (Homo sapiens)
    208. MUC1 (Homo sapiens)
    209. Muc1 (Mus musculus)
    210. MUC16 (Homo sapiens)
    211. MUC2 (Homo sapiens)
    212. MUC5B (Homo sapiens)
    213. NF2 (Homo sapiens)
    214. NRAS (Homo sapiens)
    215. NRP1 (Homo sapiens)
    216. NSCLC
    217. NUF2 (Homo sapiens)
    218. NY-ESO-1 (Homo sapiens)
    219. ny-eso-1
    220. ORF68 (Human alphaherpesvirus 3)
    221. P10
    222. PAEP (Homo sapiens)
    223. PAGR1 (Homo sapiens)
    224. PAP (Mus musculus)
    225. Pap antigen (Homo sapiens)
    226. PAX3 (Homo sapiens)
    227. PDCD1 (Homo sapiens)
    228. Pdgfrb (Mus musculus)
    229. PMEL - OBSOLETE (Homo sapiens)
    230. PMEL - obsolete (Homo sapiens)
    231. Pmel17 (Mus musculus)
    232. pp65 (Mus musculus)
    233. PRAME (Homo sapiens)
    234. Prn (Mus musculus)
    235. PROM1 (Homo sapiens)
    236. Prostate specific antigen (Mus musculus)
    237. Prostate stem cell antigen (Mus musculus)
    238. Prostate-specific membrane antigen (Homo sapiens)
    239. Prostate-specific membrane antigen (Rattus norvegicus)
    240. PSMB9 (Homo sapiens)
    241. PTPRC (Homo sapiens)
    242. PTTG1 (Homo sapiens)
    243. RANBP2 (Homo sapiens)
    244. RHD (Homo sapiens)
    245. RNF43 (Homo sapiens)
    246. ROPN1 (Homo sapiens)
    247. Rpsa (Mus musculus)
    248. RUNX1 (Homo sapiens)
    249. S (Hepatitis B virus)
    250. S100A6 (Homo sapiens)
    251. S100A9 (Homo sapiens)
    252. SCFV (Homo sapiens)
    253. SCGB2A2 (Homo sapiens)
    254. SDC1 (Homo sapiens)
    255. SDC1-Obsolete (Homo sapiens)
    256. sialyl-Tn
    257. SILV (Homo sapiens)
    258. SLAMF7 (Homo sapiens)
    259. SLC5A5 (Homo sapiens)
    260. SOX2 (Homo sapiens)
    261. SOX6 (Homo sapiens)
    262. SPA17 (Homo sapiens)
    263. SPANXB1 (Homo sapiens)
    264. SPBC17D11.03c hypothetical protein (Schizosaccharomyces pombe)
    265. SPY-1
    266. ST8SIA1 (Homo sapiens)
    267. Steap1 (Mus musculus)
    268. STEAP1 (Homo sapiens)
    269. Survivin (Homo sapiens)
    270. Survivin (Mus musculus)
    271. TAF1B (Homo sapiens)
    272. TARP (Homo sapiens)
    273. TBXT (Homo sapiens)
    274. TERT (Homo sapiens)
    275. TET1 (Homo sapiens)
    276. tetX (Clostridium tetani E88)
    277. TF (Homo sapiens)
    278. TGFB2 (Homo sapiens)
    279. Th (Mus musculus)
    280. TLR4 (Homo sapiens)
    281. TLR7 (Homo sapiens)
    282. TLR9 (Homo sapiens)
    283. TMEM37 (Homo sapiens)
    284. TNF (Homo sapiens)
    285. tnf-alpha (Oncorhynchus mykiss)
    286. TNFRSF18 (Homo sapiens)
    287. TNFSF10 (Homo sapiens)
    288. TNFSF18 (Homo sapiens)
    289. TOMM34 (Homo sapiens)
    290. TOP2A (Homo sapiens)
    291. tox1 (Corynebacterium diphtheriae PW8)
    292. TP53 - delete (Homo sapiens)
    293. TPBG (Homo sapiens)
    294. TRP-1 (Mus musculus)
    295. TRP-2 (Homo sapiens)
    296. Trp2 (Mus musculus)
    297. TRPC1 (Homo sapiens)
    298. Tumor Associated Antigen
    299. Tyrosinase (Homo sapiens)
    300. Tyrosinase from Mouse (Mus musculus)
    301. TYRP1 (Homo sapiens)
    302. Tyrp1 (Mus musculus)
    303. Ubiquitin (Mus musculus)
    304. UL122 (Human betaherpesvirus 5)
    305. UL123 (Human betaherpesvirus 5)
    306. UL83 (Human betaherpesvirus 5)
    307. UL83 (Human betaherpesvirus 5)
    308. UL97
    309. VEGFA (Homo sapiens)
    310. VHL (Homo sapiens)
    311. WHcAg (Woodchuck hepatitis virus)
    312. WT1 (Homo sapiens)
    313. Xbp1 (Mus musculus)
    314. XBP1 (Homo sapiens)
    315. Xcl1 (Mus musculus)
    316. XCL1 (Homo sapiens)
    317. YBX1 (Homo sapiens)
  3. Vaccine Information
    1. (H115D)VHL35 Peptide Vaccine
    2. 1(SOCS1)-silenced dentritic cell (DC) vaccines
    3. 117-126:FGF-5 Peptide
    4. 12MP
    5. 12MP, 12MP/Tet, 12MP/6MHP, or 6MHP
    6. 27-35(27L):MART-1 peptide vaccine
    7. 4-peptide melanoma vaccine
    8. 851B Gel
    9. A2/4-1BBL melanoma vaccine
    10. Abagovomab
    11. AcDEX-(imine) Nanoparticle Vaccine Conjugated to MUC1 Epitopes (TSAPDTRPAP/SAPDNRPAL) and R837
    12. Ad CMV I kappaB alpha
    13. Ad-sig-hMUC-1/ecdCD40L Vaccine
    14. Ad5-yCD/mutTKSR39rep-hIL12
    15. Ad5F35-LMP1/LMP2-Transduced Autologous Dendritic Cells
    16. Adenovector Encoding MDA7
    17. Adenovector-transduced AP1903-inducible MyD88/CD40-expressing Autologous PSMA-specific Prostate Cancer Vaccine BPX-201
    18. Adenoviral Vector Ad5-CEA(6D) Vaccine
    19. Adenovirus 5-CD40 Ligand
    20. Adenovirus 5-Fibroblast Growth Factor 2
    21. Adenovirus 5-Human Guanylyl Cyclase C-PADRE Vaccine
    22. Adenovirus B7-1
    23. Adenovirus Encoding Rat HER-2/neu
    24. Adenovirus Encoding Tyrosinase/MART-1/MAGEA6-transduced Autologous Dendritic Cell Vaccine
    25. Adenovirus HER2-Transduced Autologous Dendritic Cell Vaccine
    26. Adenovirus RSV-TK
    27. Adenovirus-mediated Human Interleukin-12
    28. Adenovirus-p53 Transduced Dendritic Cell Vaccine
    29. Adenovirus-PSA Prostate Cancer Vaccine
    30. adenovirus-transfected autologous DC vaccine plus CIK cells
    31. Adenovirus-vectored therapeutic vaccine (Ad-Ii-E1E2E6E7)
    32. AdRTVP-1-Transduced Prostate Cancer Cell-Based Vaccine
    33. AE37 Peptide/GM-CSF Vaccine
    34. AFP Gene Hepatocellular Carcinoma Vaccine
    35. Ag NY-ESO-1
    36. AGS-003-BLD Vaccine
    37. AIM2(-1)/HT001(-1)/TAF1B(-1) Frameshift Peptide Vaccine
    38. Algenpantucel-L
    39. ALK peptide vaccine
    40. Allogeneic AML Antigen-expressing Dendritic Cell Vaccine
    41. Allogeneic B7.1/HLA-A1 Transfected Tumor Cell Vaccine
    42. Allogeneic Cellular Vaccine 1650-G
    43. Allogeneic Dendritic Cell Vaccine COMBIG-DC
    44. Allogeneic Dendritic Cell-Myeloma Idiotype Vaccine
    45. Allogeneic Glioblastoma Stem-like Cell Line Lysate-pulsed Autologous Dendritic Cell Vaccine
    46. Allogeneic GM-CSF-Based Myeloma Cell Vaccine
    47. Allogeneic GM-CSF-Secreting Breast Cancer Vaccine
    48. Allogeneic GM-CSF-secreting Lethally Irradiated Pancreatic Tumor Cell Vaccine
    49. Allogeneic GM-CSF-secreting Tumor Vaccine PANC 10.05 pcDNA-1/GM-Neo
    50. Allogeneic GM-CSF-secreting Tumor Vaccine PANC 6.03 pcDNA-1/GM-Neo
    51. Allogeneic HLA-A2/4-1BB ligand-expressing Melanoma Vaccine
    52. Allogeneic Large Multivalent Immunogen Breast Cancer Vaccine
    53. Allogeneic Large Multivalent Immunogen Melanoma Vaccine LP2307
    54. Allogeneic Melanoma Vaccine AGI-101H
    55. Allogeneic Mesothelioma Tumor Lysate-pulsed Autologous Dendritic Cell Vaccine
    56. Allogeneic Multipotent Adult Progenitor Cells
    57. Allogeneic Renal Cell Carcinoma Vaccine MGN1601
    58. Allogeneic Tumor Cell Vaccine
    59. Allogeneic/Syngeneic DC-MC38/MUC1 Fusion Cell Vaccine
    60. Allogenic Glioma Cancer Vaccine
    61. Alpha Fetoprotein Adenoviral Vector Vaccine
    62. Alpha Fetoprotein Plasmid DNA Vaccine
    63. Alpha-1,3-galactosyltransferase-expressing Allogeneic Renal Cell Carcinoma Vaccine
    64. Alpha-fetoprotein Peptide-Pulsed Autologous Dendritic Cell Vaccine
    65. Alpha-Galactosylceramide-Pulsed Autologous Dendritic Cells
    66. alpha-GalCer-AuNP-MUC1-Tn Vaccine
    67. Alpha-type-1 Polarized Dendritic Cells
    68. ALVAC gp100 Vaccine
    69. ALVAC Vaccine
    70. ALVAC(2) Melanoma Multi-antigen Vaccine
    71. ALVAC(2)-NY-ESO-1 (M)/TRICOM Vaccine
    72. ALVAC-B7-CEA
    73. ALVAC-CEA (6D)-B7.1 Vaccine
    74. ALVAC-CEA (VCP248)
    75. ALVAC-CEA B7.1 Vaccine
    76. ALVAC-CEA Vaccine
    77. ALVAC-ESO-1 Vaccine
    78. ALVAC-hB7.1
    79. ALVAC-MART-1 Vaccine
    80. ALVAC-P53 Vaccine
    81. AMHR2-ED
    82. AML mRNA Positive Lysate Loaded Autologous Dendritic Cell Vaccine
    83. Amolimogene Bepiplasmid
    84. Androgen Receptor Ligand-binding Domain-encoding Plasmid DNA Vaccine MVI-118
    85. Ankara (MVA) and ALVAC(2) Vaccine
    86. Ankara (MVA) Vaccine
    87. Anti-CD19/CD3 Tetravalent Antibody AFM11 Vaccine
    88. Anti-CD3 x Anti-CD20 Bispecific Antibody-Armed Activated T Cells Cancer Vaccine
    89. Anti-CEA TCR Retroviral Vector-Transduced Autologous Peripheral Blood Lymphocytes
    90. Anti-CTLA4 MoAb RNA-transfected Autologous Dendritic Cell Vaccine
    91. Anti-CTLA4 MoAb RNA/GITRL RNA-transfected Autologous Dendritic Cell Vaccine
    92. Anti-GnRH Vaccine PEP223
    93. Anti-HER2/HER3 Dendritic Cell Vaccine
    94. Anti-idiotype MUC-1 Monoclonal Antibody Vaccine
    95. Anti-Idiotype Specified Monoclonal Antibody
    96. anti-idiotypic (anti-id) mAb MK2-23 + BCG
    97. Anti-idiotypic Monoclonal Antibody BEC2 Vaccine
    98. Anti-NY-ESO-1 Immunotherapeutic GSK-2241658A
    99. Anti-NY-ESO1 TCR-transduced Autologous CD62L+-derived T-Lymphocytes
    100. Anti-p53 T-Cell Receptor-Transduced Peripheral Blood Lymphocytes Vaccine
    101. Anti-PRAME Immunotherapeutic GSK2302032A Vaccine
    102. Antigen-CPP vaccine
    103. Antigen-targeted Personalized Breast Cancer Vaccine
    104. APC8015F
    105. Apoptotic Autologous Tumor Cells-pulsed Alpha-type-1 Polarized Dendritic Cells
    106. attenuated Listeria expressing cancer antigen vaccine
    107. AuNP-Conjugated Fluoroproline-Modified S-Linked Tn-MUC1 Glycopeptide Vaccine
    108. AuNP-MUC1-Tn Vaccine with (2S,3R)-3-hydroxynorvaline
    109. AUT-OV-ALVAC-hB7.1 Vaccine
    110. Autolgous DC Vaccine Pulsed with Autologous Tumor Homogenate for Metastatic RCC
    111. Autologous Ad-CD154-Transduced CLL B Cells
    112. Autologous Anti-gp100:154-162 T-Cell Receptor Gene-Engineered Peripheral Blood Lymphocytes
    113. Autologous Anti-MART-1 F5 T-Cell Receptor Gene-Engineered Peripheral Blood Lymphocytes
    114. Autologous Cancer Testis Antigen Specific Dendritic Cell Vaccine
    115. Autologous CD133-Positive BTSC mRNA-Pulsed Autologous Dendritic Cell Vaccine
    116. Autologous CD40L-expressing B-CLL Vaccine
    117. Autologous CLL Tumor Cell Vaccine
    118. Autologous CMV-pp65-flLAMP mRNA Loaded Dendritic Cell Vaccine
    119. Autologous Colorectal Tumor Antigen-pulsed Dendritic Cell Vaccine
    120. Autologous CT7/MAGE-A3/WT1 mRNA-Electroporated Langerhans-Type Dendritic Cells
    121. autologous dendritic cell vaccine (DCV)
    122. Autologous Dendritic Cell Vaccine ACT2001
    123. Autologous dendritic cell vaccine loaded with personalized peptides (PEP-DC vaccine)
    124. Autologous Dendritic Cell-Adenovirus CCL21 Vaccine
    125. Autologous Dendritic Cell-Adenovirus P53 Vaccine
    126. Autologous Dendritic Cell-Allogeneic Melanoma Tumor Cell Lysate Vaccine
    127. Autologous Dendritic Cell-Autologous Tumor mRNA-Human CD40L Vaccine
    128. Autologous Dendritic Cell-based Immunotherapeutic AV0113
    129. Autologous Dendritic Cell-Tumor Fusion Vaccine
    130. autologous dendritic cells (DCs)
    131. Autologous Dinitrophenyl Vaccine
    132. Autologous Dinitrophenyl-Modified Ovarian Cancer Vaccine
    133. Autologous EBV-Transformed B Lymphoblastoid-Tumor Fusion Cell Vaccine
    134. Autologous Epstein-Barr Virus-Transformed B-Lymphoblastoid Cell Vaccine
    135. Autologous Expanded Mesenchymal Stem Cells OTI-010
    136. Autologous GM-CSF-Secreting Breast Cancer Vaccine
    137. Autologous GM-CSF-secreting Lethally Irradiated Colorectal Cancer Cell Vaccine
    138. Autologous GM-CSF-Secreting Lethally Irradiated Leukemia Cell Vaccine
    139. Autologous Heat-Shock Protein 70 Peptide Vaccine AG-858
    140. Autologous HNSCC DNA-transfected Semi-allogeneic Fibroblasts MRC-5 Vaccine
    141. Autologous IL-2-expressing B-CLL Vaccine
    142. Autologous Immunoglobulin Idiotype-KLH Conjugate Vaccine
    143. Autologous Lymphoma Cell Lysate-Pulsed Autologous Dendritic Cell Vaccine
    144. Autologous Lymphoma Cell/Allogeneic Dendritic Cell Electrofusion Hybrid Vaccine
    145. Autologous Lymphoma Cell/Autologous Dendritic Cell Electrofusion Hybrid Vaccine
    146. Autologous Lymphoma Immunoglobulin-derived scFv-chemokine DNA Vaccine
    147. Autologous Melanoma Lysate-Pulsed Autologous Dendritic Cell Vaccine
    148. Autologous Melanoma Lysate/KLH-Pulsed Autologous Dendritic Cell Vaccine
    149. Autologous Melanoma Lysate/NY-ESO-1-pulsed Autologous Dendritic Cell Vaccine
    150. Autologous monocyte-derived mature DCs pulsed with p53, survivin and telomerase-derived peptides
    151. Autologous MUC1 peptide-pulsed DC vaccine
    152. Autologous Neuroblastoma Vaccine
    153. Autologous NSCLC DNA-Transfected Semi-Allogeneic Fibroblasts MRC-5 Vaccine
    154. Autologous NSCLC Peptide-specific Dendritic Cell Vaccine
    155. Autologous OFA-iLRP RNA-Transfected Dendritic Cell Vaccine
    156. Autologous Ovarian Tumor Cell Lysate-Pulsed Dendritic Cell Vaccine
    157. Autologous Oxidized Ovarian Tumor Cell Lysate Vaccine
    158. Autologous Pluripotent ALDHbr Stem Cells ALD-451
    159. Autologous Prostate Cancer Antigen-expressing Dendritic Cell Vaccine BPX-101
    160. Autologous Renal Cell Carcinoma Tumor Lysate-Pulsed Dendritic Cell Vaccine
    161. Autologous Sarcoma Lysate-pulsed Dendritic Cell Vaccine
    162. Autologous TARP Peptide-Pulsed Dendritic Cell Vaccine
    163. Autologous Total Tumor mRNA and CMV-pp65-flLAMP mRNA Loaded Liposome Vaccine
    164. Autologous TriMix-DC Melanoma Vaccine
    165. Autologous tumor cell lysate vaccine
    166. Autologous Tumor Cell Proteoliposome Chronic Lymphocytic Leukemia Vaccine
    167. Autologous Tumor Cell Vaccine
    168. Autologous Tumor-associated Peptide Antigen-pulsed Dendritic Cell Vaccine
    169. Autologous, DNP-Modified Ovarian Cancer Vaccine
    170. Autologous-Cell Leukemia Vaccine
    171. Autologous-Cell Melanoma Vaccine
    172. B-cell lymphoma DNA vaccine VCL-1642.XXX encoding a chimeric immunoglobulin molecule onsisting of tumor-specific variable (Id) regions
    173. B16 melanoma DNA vaccine pCMV-hTRP-1 encoding TRP-1
    174. B16 melanoma DNA vaccine pSin-hTRP-1 encoding TRP-1
    175. B16 melanoma DNA vaccine pSin-mTRP-1
    176. B16 Vaccine adjuvanted by Loxoribine
    177. B7.1/​IL-2 Leukaemia Cell Vaccine
    178. Bacille Calmette Guérin for melanoma of lower extremity
    179. Bacillus Calmette-Guerin (BCG)
    180. Bacillus Calmette-Guerin (BCG), C. parvum
    181. Bacillus Calmette-Guerin (BCG), dinitrochlorobenzene (DNCB)
    182. bacillus Calmette-Guerin (MER)
    183. BC-819
    184. BCG
    185. BCG and chemotherapy for malignant melanoma
    186. BCG and Corynebacterium parvum for malignant melanoma
    187. BCG treatment after surgical tumor removal
    188. BCG, Cell Wall Skeleton
    189. Bcl-Xl_42-CAF09b Vaccine
    190. Bcl-Xs Adenovirus Vaccine
    191. Bcr-Abl (b2a2)-Derived Peptide Vaccine
    192. Bcr-Abl (b3a2)-Derived Peptide Vaccine
    193. Bcr-abl peptide vaccine
    194. Belagenpumatucel-L
    195. Berzofsky Ras/P53 Peptide Vaccine
    196. Biolistic DNA vaccination
    197. Bivalent Vaccine with Adjuvant OPT-821
    198. Brachyury-expressing Modified Vaccinia Ankara-TRICOM Vaccine
    199. Brain Tumor Initiating Cell Vaccine
    200. C29561
    201. Canarypox-hIL-12 Melanoma Vaccine
    202. Cancer DNA Vaccine encoding Endoglin Boosted with Recombinant Endoglin Protein
    203. Cancer DNA Vaccine encoding TEM8
    204. Cancer DNA Vaccine MIDGE/hNIS encoding hNIS protein
    205. Cancer DNA vaccine p.DOM-AH1 encoding fragment C
    206. Cancer DNA Vaccine pLXSHDmB7-2 encoding Cd86
    207. Cancer DNA Vaccine pSURV encoding Survivin
    208. Cancer EPCAM protein vaccine
    209. Cancer Her-2/neu Protein Subunit Vaccine
    210. Cancer recombinant vector vaccine encoding H-2Kb
    211. Cancer Retroviral Vector Vaccine encoding Cd40lg
    212. Cancer Stem Cell DC Vaccine
    213. Cancer Subunit DC (Tat-CEA) vaccine
    214. Cancer Subunit GV1001 Protein Vaccine
    215. Cancer Subunit NY-ESO-1 Protein Vaccine
    216. Cancer Vaccine using E7 protein of human papillomavirus 16 and Algammulin
    217. Cancer Vaccine using E7 protein of human papillomavirus 16 and Quil-A
    218. Cancer VEGFA protein vaccine
    219. Canvaxin
    220. CAP-2 (CEA Peptide 9-mer)
    221. CAP-3 (CEA Peptide 9-mer)
    222. CAR G36-PDL1
    223. Carcinoembryonic Antigen Peptide 1-6D
    224. Carcinoembryonic Antigen Peptide 1-6D Virus-Like Replicon Particles Vaccine
    225. Carcinoembryonic Antigen Peptide-1 Vaccine
    226. Carcinoembryonic Antigen RNA-pulsed DC Cancer Vaccine
    227. Carcinoma DNA vaccine pVAX/E2A
    228. CD105/Yb-1/SOX2/CDH3/MDM2-polyepitope Plasmid DNA Vaccine
    229. CD133 Antigen Peptide-pulsed Autologous Dendritic Cell Vaccine
    230. CD80 Breast Cancer Vaccine
    231. CDX-1307 Vaccine
    232. CEA RNA-pulsed Autologous Human Cultured Dendritic Cells
    233. CEA/Tetanus Toxoid T Helper Epitope Fusion Protein-Expressing DNA Plasmid Vaccine
    234. Chimeric Ad11p/Ad3 Oncolytic Virus
    235. Chimeric exosomal tumor vaccine
    236. Class I HLA-A*0201-restricted gp100209-2M peptide vaccine
    237. CLL Idiotypic DNA Vaccine
    238. CMV pp65 Peptide-pulsed Autologous Dendritic Cell Vaccine
    239. CMVpp65/gB Plasmid Vaccine ASP0113
    240. Colorectal cancer DNA vaccine pCEA/HBsAg encoding carcinoembryonic antigen and hepatitis B surface antigen
    241. Contusugene ladenovec
    242. Corynebacterium parvum, DTIC
    243. CpG 7909/PF3512676
    244. CRM197-tetraMUC1-Tn Conjugate Vaccine
    245. CTP-37-DT Vaccine
    246. CVB4/p24(73(3))
    247. Cyclin B1 Peptide-pulsed Autologous Dendritic Cell Vaccine
    248. Cyclin B1/WT-1/CEF-Loaded DC Vaccine
    249. Cytokine-Induced Killer Cells
    250. DC/AML Fusion Vaccine
    251. Dendritic Cell Survivin Vaccine
    252. Dendritic Cell Tumor Cell Lysate Vaccine
    253. Dendritic Cell Tumor Peptide Vaccine
    254. Dendritic Cell-Autologous Lung Tumor Vaccine
    255. Dendritic Cell-CEA Peptide Vaccine
    256. Dendritic Cell-gp100-MART-1 Antigen Vaccine
    257. Dendritic Cell-Idiotype-Keyhole Limpet Hemocyanin Vaccine
    258. Dendritic Cell-MART-1 Peptide Vaccine
    259. Dendritic Cell-Recombinant Prostate-Specific Membrane Antigen Vaccine
    260. Dendritic Cell-targeting Lentiviral Vector ID-LV305
    261. Dendritic Cell/​Myeloma Fusion Vaccine
    262. Dendritic vaccine, allogeneic hematopoietic stem cells, cytotoxic lymphocytes
    263. Dendritic vaccine, autologous hematopoietic stem cells, cytotoxic lymphocytes
    264. DEPDC1/MPHOSH1 Peptide Vaccine
    265. Dinitrophenyl-Modified Autologous Renal Cell Carcinoma Tumor cell Vaccine
    266. DIPG and GMB Immunomodulatory DC Vaccine
    267. DLK1/EPHA2/HBB/NRP1/RGS5/TEM1 Peptide-pulsed Alpha-type-1 Polarized Dendritic Cell Vaccine
    268. DNA Plasmid Encoding Interleukin-12 INO-9012
    269. DNA Plasmid-encoding Interleukin-12/HPV DNA Plasmids Therapeutic Vaccine INO-3112
    270. DNA Vaccine encoding p42.3
    271. DNA Vaccine VB10.16
    272. DNA Vector pPRA-PSM Vaccine
    273. DNP-modified autologous vaccine
    274. E1M(184V) Peptide Vaccine
    275. EF-1 Peptide Vaccine
    276. EF-2 Peptide Vaccine
    277. EGFRvIII Peptide Vaccine
    278. Electrofusion DC vaccine
    279. electroloading of mature dendritic cells with melanoma whole tumor cell lysate
    280. Emepepimut-S Vaccine
    281. EP-2101 Vaccine
    282. ESAT-6-gpi DNA vaccine combined with B16F10-ESAT-6-gpi/IL-21 vaccine
    283. ESO-1 (161-180) Peptide Vaccine
    284. ESO-1 Reactive Autologous Peripheral Blood Lymphocyte Vaccine
    285. ESO-1:157-165(165V) Peptide Vaccine
    286. ESR1 peptide vaccine
    287. Falimarev Vaccine
    288. Fas-Chimera Transgene-expressing Endothelial Tumor Cell-targeting Adenovector VB-111 Vaccine
    289. Flagrp170
    290. Folate-FITC Vaccine
    291. Follicular lymphoma, patient-specific, soluble protein idiotype vaccine
    292. Fowlpox Virus Vaccine
    293. Fowlpox Virus Vaccine Vector
    294. Fowlpox-NY-ESO-1 Vaccine
    295. Fowlpox-PSA-TRICOM Vaccine
    296. FRAME-001 personalized vaccine
    297. FrSh61 (MEA) VHL33 Peptide Vaccine
    298. FVAX
    299. G250 Peptide Vaccine
    300. Gag:267-274 Peptide Vaccine
    301. GD2-CAR
    302. GD2L, GD3L, Globo H, fucosyl GM1, and N-propionylated polysialic acid KLH Conjugate Vaccine
    303. Genetically Engineered Allogeneic Prostate Carinoma Cells Secreting Interleukin-2 and Interferon Gamma
    304. GITRL RNA-transfected Autologous Dendritic Cell Vaccine
    305. Glioma-Associated Antigen Peptide-Pulsed Autologous Dendritic Cell Vaccine
    306. Glioma-associated Peptide-loaded Dendritic Cell Vaccine SL-701
    307. Globo H-DT Vaccine OBI-833
    308. Globo H-GM2-Lewis-y-MUC1-32-mer-TF(c)-Tn(c)-KLH Conjugate Vaccine
    309. Globo-H-GM2-Lewis-y-MUC1-32(aa)-sTn(c)-TF(c)-Tn(c)-KLH Conjugate Vaccine
    310. Glypican-3-derived peptide vaccine for human hepatocellular carcinoma
    311. GM-CSF transfected cells vaccine
    312. GM-CSF, IL-12 and GM-CSF+IL-12 genetically modified tumor cell vaccine
    313. GM-CSF-encoding Oncolytic Adenovirus CGTG-102 Vaccine
    314. GM-K562 cell vaccine
    315. GM.CD40L Cell Vaccine
    316. GM2/GD2/GD3 Lactone-KLH Conjugate Trivalent Vaccine
    317. Golnerminogene Pradenovec Vaccine
    318. gp100 + Mart-1 + Mart-3 Vaccine
    319. gp100 Adenovirus Vaccine
    320. gp100 and GM-CSF DNA/Gold Vaccine
    321. gp100 mature dendritic cell vaccine
    322. gp100 Protein (184V) Vaccine
    323. gp100 Vaccine
    324. gp100 Vaccinia Vaccine
    325. gp100-Fowlpox Vaccine
    326. gp100-Pulsed Peripheral Blood Mononuclear Cell Vaccine
    327. gp100-Reactive Autologous Peripheral Blood Lymphocyte Vaccine
    328. gp100/IFA Vaccine
    329. gp100: ES209-217(210M) Peptide Vaccine
    330. gp100:154-162 Peptide Vaccine
    331. gp100:209-217 Peptide Vaccine
    332. gp100:209-217(210M) peptide vaccine
    333. gp100:280-288 Peptide Vaccine
    334. gp100:280-288(288V) Peptide Vaccine
    335. gp96-secreting Allogeneic Bladder Cancer Cell Vaccine HS-410
    336. GVAX Cancer Vaccine
    337. GVAX Leukemia Vaccine
    338. GVAX Lung Cancer Vaccine
    339. GVAX Pancreatic Cancer Vaccine
    340. H3.3K27M-specific Peptide Vaccine
    341. hapten dinitrophenyl
    342. HCA587 protein vaccine
    343. HCV DNA Vaccine INO-8000
    344. HER-2-neu, CEA peptides, GM-CSF, Montanide ISA-51 vaccine
    345. HER2 ECD+TM Virus-like Replicon Particles Vaccine AVX901
    346. HER2 ICD peptide vaccine
    347. HER2-pulsed Autologous Type-1 Polarized Dendritic Cell Vaccine
    348. Hexapeptide melanoma vaccine
    349. HLA Neoantigen Vaccine
    350. HLA-A*0201-Restricted TRP2-gp100-EphA2-HER2 multipeptide Vaccine
    351. HLA-A*0201-Restricted URLC10-VEGFR1-VEGFR2 Multipeptide Vaccine
    352. HLA-A*0201-Restricted VEGFR1 Peptide Vaccine
    353. HLA-A*2402-Restricted VEGFR1 Peptide Vaccine
    354. HLA-A*2402-Restricted VEGFR1/2 Multipeptide Vaccine
    355. HLA-A*2404-Restricted RNF43-TOMM34-VEGFR1-VEGFR2 Multipeptide Vaccine
    356. HLA-A1, A2, B35-Restricted Survivin Peptides/Montanide ISA-51 Vaccine
    357. HLA-A1, HLA-A2, and CD40-Ligand Pulsed Dendritic Cell Vaccine
    358. HLA-A1-Binding MAGE-1/MAGE-3 Multipeptide-Pulsed Autologous Dendritic Cell Vaccine
    359. HLA-A2, A3-Restricted FGF-5 Peptides/Montanide ISA-51 Vaccine
    360. HLA-A2-Binding TYR/MART-1/gp100 Multipeptide-Pulsed Autologous Dendritic Cell Vaccine
    361. HLA-A2-Restricted Synthetic Glioma Antigen Peptides Vaccine
    362. HLA-Matched Donor Mononuclear Cell-Enriched Leukocytes Apocell Vaccine
    363. hMART-IT
    364. Hodgkin's antigens-GM-CSF-expressing cell vaccine
    365. Host Dendritic Cell Vaccine-001 MSSM/BIIR
    366. HPV 16 E6 (18-26) Peptide Vaccine
    367. HPV 16 E7:12-20 Peptide Vaccine
    368. HPV 16 E7:86-93 Peptide Vaccine
    369. HPV 16 L1-VLP Vaccine
    370. HPV 18 E6:13-21 Peptide Vaccine
    371. HPV 18 L1-VLP Vaccine
    372. HPV DNA Plasmids Therapeutic Vaccine VGX-3100
    373. HPV E6/E7 DNA Vaccine GX-188E
    374. HPV E6/E7-encoding Semliki Forest Virus Vaccine Vvax001
    375. HPV-11 Vaccine
    376. HPV-6-targeting Immunotherapeutic Vaccine INO-3106
    377. HPV16 E6/E7 Melanoma Vaccine
    378. HSP65-HER2 fusion peptide
    379. Hsp70 chaperone-based gel composition
    380. HSPPC-96
    381. hTERT I540/R572Y/D988Y Multipeptide Vaccine
    382. hTERT mRNA/Survivin Peptide-double-loaded Autologous Dendritic Cell Vaccine
    383. hTERT Multipeptide/Montanide ISA-51 VG/Imiquimod Vaccine GX 301
    384. hTERT Vaccine V934/V935
    385. hTERT-LAMP mRNA-loaded Autologous Dendritic Cell Vaccine GRNVAC1
    386. hTERT/Survivin/CMV Multipeptide Vaccine
    387. hTERT/Survivin/Melanoma Tumor Cell-Derived mRNA-Transfected Dendritic Cell Vaccine
    388. human leukocyte antigen class I-modified peptides
    389. Human Myeloid Progenitor Cells CLT-008 Vaccine
    390. Human Papilloma Virus L1 Virus-Like Particle V504 Vaccine
    391. Human Papillomavirus 16 E7 Peptide/Padre 965.10 Vaccine
    392. Human Papillomavirus 16/18 L1 Virus-Like Particle/AS04 Vaccine
    393. Human Papillomavirus Tumor Antigen Vaccine
    394. Human Papillomavirus Vaccine V503
    395. Human Prostate-Specific Membrane Antigen Plasmid DNA Vaccine
    396. HUVECs-OK432 vaccine
    397. hVEGF26-104/RFASE Peptide Vaccine
    398. HyperAcute - Breast cancer vaccine
    399. HyperAcute-Melanoma Vaccine
    400. HyperAcute-Prostate Cancer Vaccine
    401. ICT-121 Dendritic Cell Vaccine
    402. IDD-3
    403. IDH1R132H Mutation-targeting IDH1 Peptide Vaccine
    404. IDH1R132H-Specific Peptide Vaccine PEPIDH1M
    405. Idiotype-Pulsed Autologous Dendritic Cell Vaccine APC8020
    406. IDO peptide vaccine
    407. IFN/tremem
    408. IgG3-Fc-Conjugated Liposomal Pam3CysSK4-MUC1-Tn Vaccine
    409. IL-12-expressing Mesenchymal Stem Cell Vaccine GX-051
    410. IL-12p70
    411. IL-2, Peptide, and GM-CSF-in-adjuvant Melanoma Vaccine
    412. IL-2/Lptn Gene-Modified Allogeneic Neuroblastoma Tumor Cell Vaccine
    413. IL15-DC Vaccine
    414. IMM-101
    415. ImMucin (MUC1-SP) Vaccine
    416. Immunotherapeutic GSK1572932A
    417. IMT-1012 Immunotherapeutic Vaccine
    418. Inactivated Vaccinia Virus
    419. Inalimarev Vaccine
    420. Incomplete Freund's adjuvant (IFA) alone, or a melanoma vaccine in IFA
    421. Indium In 111-Labeled Autologous Peripheral Blood Mononuclear Cells Vaccine
    422. Indium In 111-Labeled Autologous Polymorphonuclear Leukocytes Vaccine
    423. Indoleamine 2,3-dioxygenase Peptide Vaccine
    424. Interferon-gamma-expressing Adenovirus Vaccine ASN-002
    425. Interleukin-2 Anti-Idiotype Vaccine
    426. Intracel KLH Vaccine
    427. intralesional bacile Calmette-Guérin (BCG)
    428. intralesional bacile Calmette-Guérin (BCG), DTIC, vincristine
    429. Ipilimumab
    430. Ipilimumab
    431. ipilimumab, vemurafenib
    432. irradiated autologous cells
    433. irradiated melanoma cells plus BCG
    434. α-GalCer-loaded tumor-cell vaccine
    435. KLH and Tumor Lysate Pulsed DC Vaccine
    436. KLH-FITC Vaccine
    437. KLH-id Vaccine
    438. KLH-Lymphoma Ig Vaccine
    439. KLH-pulsed autologous dendritic cell vaccine
    440. KRAS-targeted mRNA vaccine
    441. KSA-KLH Conjugate Vaccine
    442. L612 HuMAb
    443. Lapuleucel-T Vaccine
    444. Large Multivalent Immunogen (LMI) vaccine
    445. Leukemic Apoptotic Corpse-Pulsed Autologous Dendritic Cells Vaccine
    446. Light-Emitting Oncolytic Vaccinia Virus GL-ONC1 Vaccine
    447. Liposomal HPV-16 E6/E7 Multipeptide Vaccine PDS0101
    448. Live-attenuated Double-deleted Listeria monocytogenes Bacteria JNJ-64041809
    449. Live-attenuated Double-deleted Listeria monocytogenes Bacteria JNJ-64041809 Vaccine
    450. Live-attenuated Listeria monocytogenes-encoding EGFRvIII-NY-ESO-1 Vaccine ADU-623
    451. LMP-2:340-349 Peptide Vaccine
    452. LMP-2:419-427 Peptide Vaccine
    453. LMP2A-loaded conventional DC vaccine
    454. Long Peptide Vaccine 7
    455. long-peptide vaccine and mAb
    456. LY6K/VEGFR1/VEGFR2 Multipeptide Vaccine
    457. Lymphoma DNA vaccine VαVβVβ-FrC
    458. mAb PC61 and DC/tumor fusion
    459. MAGE-1 Vaccinia Contaminated with BVDV
    460. MAGE-3.A1 Peptide Vaccine
    461. MAGE-A1, Her-2/neu, FBP peptides ovarian cancer vaccine
    462. MAGE-A1/MAGE-A3/NY-ESO-1 Peptides Vaccine
    463. MAGE-A12:170-178
    464. MAGE-A3 + AS15
    465. MAGE-A3 Peptide Vaccine
    466. MAGE-A3-expressing Adenovirus Type 5 Vaccine
    467. MAGE-A3-genetically modified lymphocytes
    468. MAGE-A3/HPV 16 Peptide Vaccine
    469. Malignant Glioma Tumor Lysate-Pulsed Autologous Dendritic Cell Vaccine
    470. Mammaglobin-A DNA Vaccine
    471. Maraba virus MG1 Vaccine
    472. MART-1
    473. MART-1 Adenovirus Vaccine
    474. MART-1 Fowlpox Vaccine
    475. MART-1 Vaccinia Vaccine
    476. MART-1, tyrosinase and MAGE-A6 Autologous DC Vaccine
    477. MART-1/gp100/Tyrosinase/MAGE-A3 Peptides-loaded Irradiated Allogeneic Plasmacytoid Dendritic Cells Vaccine
    478. MART-1:26-35(27L) Peptide Vaccine
    479. MART-1:27-35 Peptide Vaccine
    480. Mature dendritic cell melanoma vaccine
    481. MCMV-TRP2
    482. mCRT-vGPCR-coated whole-cell vaccine
    483. MDX-1379 (gp100) Melanoma Peptide Vaccine
    484. MDX-CTLA4 Antibody/Tyrosinase/gp100/MART-1 Melanoma Vaccine
    485. Melacine
    486. Melan-A VLP Vaccine
    487. Melan-A/MAGE-3.DP4 Peptide Vaccine
    488. Melan-A/Mart-1
    489. Melanoma DNA vaccine gp75 DNA encoding melanosomal membrane glycoproteins, gp75
    490. Melanoma DNA vaccine hTRP2 encoding TRP-2
    491. Melanoma DNA vaccine hugp100 encoding gp100
    492. Melanoma DNA vaccine pCR3.1-VS-HSP65-TP-GRP6-M2 encoding 6 tandem repeats of GRP
    493. Melanoma DNA vaccine pN4a-MAGE-1-GM
    494. Melanoma DNA vaccine pNL3-MAGE-1-GM
    495. Melanoma DNA vaccine pUB-TRP-2 encoding a fusion protein linking murine ubiquitin (UB) to the N-terminus of the full-length mTRP-2
    496. Melanoma DNA vaccine SINCp c-muMUC18 encoding MCAM/MUC18
    497. Melanoma DNA vaccine TA2Mâ„¢ encoding tyrosinase peptides
    498. Melanoma DNA vaccine VR-S8/VR-IL2/AD-S8 encoding survivin
    499. Melanoma DNA vaccine VR1012/mPmel17
    500. Melanoma DNA vaccine xenogeneic DNA encoding murine tyrosinase
    501. melanoma helper peptide vaccine
    502. Melanoma recombinant vector vaccine rVVmTRP-1 encoding TRP-1
    503. Melanoma Theraccine
    504. Melanoma-specific Melan-A/Mart-1 peptide + virus-like nanoparticles
    505. Melapuldencel-T Vaccine
    506. MELITAC 12.1 Peptide Vaccine
    507. Mesothelioma Tumor Lysate-Pulsed Autologous Dendritic Cell Vaccine
    508. Methanol Extraction Residue of BCG
    509. MG1-hDCT Vaccine
    510. MiHA-loaded PD-L1/L2-silenced Dendritic Cell Vaccine
    511. Mimotope-P10s-PADRE Peptide Vaccine
    512. Mixed bacterial vaccine
    513. Modified Vaccinia Ankara (Bavarian Nordic)-HER2 Vaccine
    514. Modified Vaccinia Virus Ankara Vaccine Expressing p53
    515. Monoclonal Antibody 105AD7 Anti-idiotype Vaccine
    516. Monoclonal Antibody 11D10 Anti-Idiotype Vaccine
    517. Monoclonal Antibody 3H1 Anti-Idiotype Vaccine
    518. Monoclonal Antibody 4B5 Anti-Idiotype Vaccine
    519. Monoclonal Antibody A1G4 Anti-Idiotype Vaccine
    520. Monoclonal Antibody GD2 Anti-Idiotype Vaccine
    521. Montanide ISA-51/Survivin Peptide Vaccine
    522. Mouse gp100 Plasmid DNA Vaccine
    523. Mouse Prostate-Specific Membrane Antigen Plasmid DNA Vaccine
    524. mouse/human gp10025-33 peptide plus CpG adjuvant; mouse/human gp100; mouse/human gp10025-33 peptide-pulsed DCs
    525. MOv-PBL Vaccine
    526. mRNA neoantigen tumor vaccine
    527. mRNA tumor antigen DC vaccine
    528. mRNA-based Personalized Cancer Vaccine NCI-4650
    529. mRNA-Derived Prostate Cancer Vaccine CV9103
    530. mRNA-electroporated dendritic cells encoding gp100 and tyrosinase as melanoma vaccine
    531. MSCV-MGMT(P140K) Vaccine
    532. MT-201-GBM monocyte vaccine
    533. MUC-1 Peptide Vaccine
    534. MUC-2-Globo H-KLH Conjugate Vaccine
    535. MUC-2-KLH Vaccine
    536. MUC1 (Glyco)peptide Vaccine: KLH/MAP-4/chimeric
    537. MUC1 100mer Peptide Vaccine with SB-AS2
    538. MUC1 105mer Peptide/BCG Vaccine
    539. MUC1 140mer Peptide Vaccine with GM-CSF or SB-AS2
    540. MUC1 22mer Peptide Vaccines (APG, SAP)
    541. MUC1 24-mer Peptide-Loaded PLGA Microsphere Vaccine
    542. MUC1 9mer (Glyco)peptide Vaccines (APG, SAP, APG-Tn, SAP-Tn)
    543. MUC1 Peptide-Poly-ICLC Vaccine
    544. MUC1 Tn/T-T9 Glycopeptide-BSA Conjugate Vaccine
    545. MUC1(16-mer)-KLH vaccine [BP16-KLH]
    546. MUC1(Tn)/MUC1(STn)/MUC1(2,3-ST)–TT Mosaic Glycopeptide Vaccine
    547. MUC1-KLH + GD3-KLH Conjugate Vaccine with Adjuvants (QS-21+CpG/GPI-0100)
    548. MUC1-KLH Vaccine/QS21
    549. MUC1-KLH/DHBcAg conjugate vaccine
    550. MUC1-targeted Peptide GO-203-2C Vaccine
    551. MUC1-Tn alpha/beta-Glycopeptide AuNP Vaccine
    552. MUC1-Tn–TT epitope–FSL-1 tricomponent vaccine
    553. MUC1-VNTR1 Peptides with Asn Substitutions at O-Glycosylation Sites: T3N, T10,18N (PD Context) and T3,11,16N, S2,T3,11,S12,T16N (GS Context) Variants
    554. Multi-epitope Folate Receptor Alpha Peptide Vaccine
    555. Multi-epitope Folate Receptor Alpha-loaded Dendritic Cell Vaccine
    556. Multi-epitope HER2 Peptide Vaccine TPIV100
    557. Multi-epitope melanoma peptide vaccine
    558. Multi-glioblastoma-peptide-targeting Autologous Dendritic Cell Vaccine ICT-107
    559. Multi-peptide CMV-Modified Vaccinia Ankara Vaccine
    560. Multiantigen Liposome Loaded Dendritic Cell Vaccine
    561. Multipeptide melanoma vaccine
    562. Multipeptide Vaccine S-588210
    563. Multipeptide XS15 Vaccine
    564. Multiple Signals loaded Dendritic Cells Vaccine
    565. Multivalent immunotherapeutic vaccine
    566. Murine TYRP2 Plasmid DNA Vaccine
    567. Mutant p53 Peptide Pulsed Dendritic Cell Vaccine
    568. Mutated neopeptide vaccine
    569. MVA-BN-CV301
    570. MVA-EBNA1/LMP2 Vaccine
    571. MVA-FCU1 TG4023 Vaccine
    572. MVA-MUC1-IL2 Vaccine (TG4010)
    573. MVA-PSA/PAP Prostate Cancer Vaccine
    574. MVF-HER-2(597-626)/MVF-HER-2 (266-296) Peptide Vaccine
    575. MVF-HER-2(628-647)-CRL 1005 vaccine
    576. NA-17/MAGE-3.A2/NY-ESO-1 Peptide Vaccine
    577. NA17.A2 Peptide Vaccine
    578. Natural Killer Cells ZRx101 Vaccine
    579. Nelipepimut-S Plus GM-CSF Vaccine
    580. NEO-PV-01 vaccine
    581. Neoantigen DNA Vaccine
    582. Neoantigen Peptide Vaccine
    583. neoantigen synthetic long peptide vaccine
    584. Neoantigen-loaded Autologous Dendritic Cell Vaccine
    585. Neuroblastoma DNA vaccine HuDsec
    586. Newcastle disease virus lysate
    587. NY-ESO-1 Peptide Vaccine
    588. NY-ESO-1 Plasmid DNA Cancer Vaccine
    589. NY-ESO-1(157-165) Peptide-pulsed Autologous Dendritic Cell Vaccine
    590. NY-ESO-1, MAGE-A1, and MAGE-A3 Dendritic Cell Vaccine
    591. NY-ESO-1/GLA-SE Vaccine ID-G305AmN
    592. NY-ESO-1/LAGE-1 Peptide Vaccine
    593. NY-ESO-1/MART-1 Peptide-pulsed Dendritic Cell Vaccine
    594. NY-ESO-1/PRAME/MAGE-A3/WT-1 Peptide Vaccine
    595. NY-ESO-1b Peptide Vaccine
    596. NY-ESO-B Vaccine
    597. OCDC and NeoDC Vaccine
    598. Oncolytic Adenovirus Encoding GM-CSF Vaccine
    599. Oncovax-ID/IL-2 Vaccine
    600. ONYX-015 Vaccine
    601. Oral Bacille Calmette-Guérin for malignant melanoma
    602. Oral Cancer Vaccine V3-OVA
    603. Oral Therapeutic Vaccine V3-X
    604. OVA-TEXO
    605. Ovapuldencel-T Vaccine
    606. Ovarian Cancer Peptide Vaccine
    607. Ovarian Cancer Stem Cell/hTERT/Survivin mRNAs-loaded Autologous Dendritic Cell Vaccine
    608. Ovarian Tumor Antigen-activated Autologous Dendritic Cell Vaccine
    609. p.DOM-WT1-126 DNA Vaccine
    610. p.DOM-WT1-37 DNA Vaccine
    611. P30-linked EphA2/CMV pp65/Survivin Peptide Vaccine P30-EPS
    612. P501-AS15 vaccine
    613. p53 Peptide Vaccine
    614. P53-Synthetic Long Peptides Vaccine
    615. PA-1-STK Ovarian Carcinoma Vaccine
    616. PADRE-CMV Fusion Peptide Vaccine
    617. Pancreatic tumor personalized neoantigen vaccine
    618. PAX3/FKHR Peptide Vaccine
    619. pcDNA3-MCC/ST
    620. pCEP4-MUC1 cDNA Plasmid DNA Vaccine
    621. PCLUS 3-18MN Vaccine
    622. PCLUS 6.1-18MN Vaccine
    623. pCR3.1-VS-HSP65-TP-GRP6-M2
    624. PD-L1 peptide vaccine
    625. PD-L1/IDO Peptide Vaccine IO102-103
    626. PEP-3-KLH Conjugate Vaccine
    627. PEP-CMV Vaccine
    628. Personal neoantigen cancer vaccine
    629. Personalized follicular lymphoma vaccine
    630. Personalized mature dendritic cell vaccine
    631. Personalized NeoAntigen Melanoma Vaccine
    632. Personalized Synthetic Long Peptide Breast Cancer Vaccine
    633. Pexastimogene-devacirepvec Vaccine
    634. PF-04948568 Vaccine
    635. Plasmacytoid Dendritic Cell Vaccine
    636. pNGVL3-hICD Vaccine
    637. pNGVL4a-CRT/E7(detox) DNA Vaccine
    638. pNGVL4a-Sig/E7(detox)/HSP70 DNA Vaccine
    639. Poliovirus vector expressing model antigen H2-Kb-restricted CTL epitope
    640. Poly Microsphere Encapsulated HER2/neu Oral Vaccine
    641. PolyPEPI1018 CRC Vaccine
    642. Polyvalent melanoma vaccine
    643. PR-151 Peptide Vaccine
    644. PR1 Leukemia Peptide Vaccine
    645. Primary Prostate Cancer Tissue/hTERT/Survivin mRNA-loaded Autologous Dendritic Cell Vaccine
    646. prime/boost DC-TRP-2 melanoma vaccine
    647. procarbazine, dactinomycin, velba
    648. Prodencel
    649. Prostate cancer DNA vaccine encoding PSCA
    650. Prostate cancer DNA vaccine hPSMAt encoding PSMA
    651. Prostate cancer DNA vaccine pcDNA3-STEAP encoding six-transmembrane epithelial antigen
    652. Prostate cancer DNA vaccine pDOM-PSMA27 encoding PSMA
    653. Prostate cancer DNA vaccine pmPSCA encoding PSCA
    654. Prostate cancer DNA vaccine PSCA-HSP encoding PSCA and HSP
    655. Prostate cancer DNA vaccine psig-3P-Fc encoding 3P(hPSM, hPAP, or hPSA)-Fc fusion protein
    656. Prostate cancer DNA vaccine pVax-PSA
    657. Prostate cancer DNA vaccine rPSMAt encoding PSMA
    658. Prostate Cancer Vaccine ONY-P1
    659. Prostate Tumor Antigen-activated Autologous Dendritic Cell Vaccine
    660. PROSTVAC-Contaminated W/ BVDV
    661. PSA Prostate Cancer Vaccine
    662. PSA RNA-Pulsed Dendritic Cell Vaccine
    663. PSA-OP Peptide Vaccine
    664. PSA-PAP/KLH-pulsed Autologous Dendritic Cell Vaccine
    665. PSA/IL-2/GM-CSF Vaccine
    666. PSA/PSMA DNA Plasmid INO-5150 Vaccine
    667. PSA:154-163 Peptide Vaccine
    668. PSA:154-163(155L) Peptide Vaccine
    669. PSMA/TARP Peptide Vaccine
    670. pTVG-HP Plasmid DNA Vaccine
    671. Pulmonary BCG immunotherapy for malignant melanoma
    672. pUMVC3-hIGFBP-2 Multi-Epitope Plasmid DNA Vaccine
    673. pUMVC3-IGFBP2-HER2-IGF1R Plasmid DNA Vaccine
    674. pVAXrcPSAv53l DNA Vaccine
    675. Quadrivalent Human Papillomavirus (types 6, 11, 16, 18) Recombinant Vaccine
    676. Qβ-MUC1-Tf/STn Vaccine
    677. Racotumomab Vaccine
    678. RAS Peptide Cancer Vaccine
    679. RAS Peptide Cancer Vaccine TG01
    680. RASVAC-C Vaccine
    681. RASVAC-V Vaccine
    682. RCAS-Akt Vaccine
    683. RCAS-Ras Vaccine
    684. Recombinant Adenovirus 5 Encoding Tumor Necrosis Factor-related Apoptosis-Inducing Ligand Vaccine
    685. Recombinant Adenovirus-Cre Recombinase Vaccine
    686. Recombinant Adenovirus-hIFN-beta Vaccine
    687. Recombinant Adenovirus-Interferon/Syn3 Vaccine
    688. Recombinant Adenovirus-L523S Vaccine
    689. Recombinant Adenovirus-LacZ Vaccine
    690. Recombinant Adenovirus-p53 SCH-58500 Vaccine
    691. Recombinant Anti-WT1 Immunotherapeutic GSK2302024A Vaccine
    692. Recombinant Colorectal cancer antigen GA733 Vaccine
    693. Recombinant dHER2 Vaccine
    694. Recombinant DNA-L523S Vaccine
    695. Recombinant Fowlpox GM-CSF Vaccine Adjuvant
    696. Recombinant Fowlpox-B7.1 Vaccine
    697. Recombinant Fowlpox-CEA(6D)/TRICOM Vaccine
    698. Recombinant Fowlpox-gp100p209 Vaccine
    699. Recombinant Fowlpox-Mgp100 Vaccine
    700. Recombinant Fowlpox-Prostate Specific Antigen Vaccine
    701. Recombinant Fowlpox-PSA(L155)/TRICOM Vaccine
    702. Recombinant Fowlpox-TRICOM Vaccine
    703. Recombinant Fowlpox-Tyrosinase Vaccine
    704. Recombinant Human EGF-rP64K/Montanide ISA 51 Vaccine
    705. Recombinant Human Fusion Protein L19TNFalpha Vaccine
    706. Recombinant Human Hsp110-gp100 Chaperone Complex Vaccine
    707. Recombinant Human MUC1-Oxidized Polymannose-pulsed Autologous Dendritic Cell Vaccine
    708. Recombinant Human Papillomavirus Nonavalent Vaccine
    709. Recombinant Modified Vaccinia Ankara-5T4 Vaccine
    710. Recombinant NY-ESO-1 ISCOMATRIX Vaccine
    711. Recombinant NY-ESO-1 Protein vaccine adjuvanted with Imiquimod
    712. Recombinant Saccharomyces Cerevisia-CEA(610D)-Expressing Vaccine GI-6207
    713. Recombinant Vaccinia DF3/MUC1 Vaccine
    714. Recombinant Vaccinia PSA Vaccine
    715. Recombinant Vaccinia Viral Vector RO5217790 Vaccine
    716. Recombinant Vaccinia-CEA Vaccine
    717. Recombinant Vaccinia-CEA(6D)-TRICOM Vaccine
    718. Recombinant Vaccinia-gp100:209-217 Vaccine
    719. Recombinant Vaccinia-Mgp100 Vaccine
    720. Recombinant Vaccinia-MUC-1 Vaccine
    721. Recombinant Vaccinia-MUC1-B7 Vaccine
    722. Recombinant Vaccinia-Multiepitope Melanoma Peptides-B7.1-B7.2 Vaccine
    723. Recombinant Vaccinia-NY-ESO-1 Vaccine
    724. Recombinant Vaccinia-Prostate Specific Antigen Vaccine
    725. Recombinant Vaccinia-PSA/PSMA Vaccine
    726. Recombinant Vaccinia-TRP1 Vaccine
    727. Remestemcel-L Vaccine
    728. Renal Cell Carcinoma Peptides Vaccine IMA901
    729. Renal Cell Carcinoma/CD40L RNA-Transfected Autologous Dendritic Cell Vaccine AGS-003
    730. Renal Tumor-Reactive Autologous Peripheral Blood Lymphocyte Vaccine
    731. Retrovector Encoding Mutant Anti-Cyclin G1 Vaccine
    732. Retroviral Vector MFGS-MOv18-gamma Vaccine
    733. rF-MUC1(DF3)/TRICOM Vaccine
    734. rF-PSA/PSMA/TRICOM Vaccine
    735. Rilimogene-galvacirepvec Vaccine
    736. RIPO(H3.3)
    737. rMCMV-TRP2
    738. rMeV- SCD
    739. rMVTT- HPV16-E6/E7
    740. Sargramostim Plasmid DNA Melanoma Vaccine Adjuvant
    741. Sargramostim Plasmid DNA Pancreatic Tumor Cell Vaccine
    742. SCIB1 DNA vaccine
    743. secPD-L1
    744. Self-Adjuvanting AuNP MUC1 Glycopeptide Vaccine with S-Glycosidic Linkage (SThr) and (4S)-4-fluoro-L-proline
    745. short overlapping peptides and full-length recombinant protein
    746. Sialyl Lewis-keyhole limpet hemocyanin conjugate vaccine
    747. Sialyl Tn-KLH Vaccine
    748. Sipuleucel-T Vaccine
    749. Site-Specifically Conjugated CRM197-MUC1 APDTRP Glycopeptide Vaccine with S-Glycosidic Tn and (4S)-4-Fluoro-L-Proline
    750. smallpox vaccine
    751. sp²-Iminosugar Tn Mimic MUC1 Glycopeptide-KLH Conjugate Vaccine
    752. SRL172
    753. STn-KLH plus Detox Vaccine
    754. STn-MUC1-CRM197 Conjugate Vaccine with MPL/QS21
    755. STn-MUC1-TTox vaccine
    756. Survivin Antigen Vaccine DPX-Survivac
    757. Survivin Sur1M2 Peptide Vaccine
    758. Survivin/p53/HER2 Antigen-loaded Autologous Dendritic Cell Vaccine
    759. SVN53-67/M57-KLH Peptide Vaccine
    760. Synchotrope TA2M Vaccine
    761. Synchrotope TA2M Plasmid DNA Vaccine
    762. Synchrovax SEM Plasmid DNA Vaccine
    763. Synthetic Breast Cancer Peptides-Tetanus Toxoid-Montanide ISA-51 Vaccine
    764. Synthetic Glioblastoma Mutated Tumor-specific Peptides Vaccine Therapy APVAC2
    765. Synthetic Glioblastoma Tumor-associated Peptides Vaccine Therapy APVAC1
    766. Synthetic hTERT DNA Vaccine INO-1400
    767. Synthetic Long E6/E7 Peptides Vaccine HPV-01
    768. Synthetic Melanoma-Associated Antigens Vaccine
    769. Synthetic Peptides E-PRA And E-PSM Vaccine
    770. SZU251 + MUC1 + Al vaccine
    771. TARP 27-35 Peptide Vaccine
    772. TARP 29-37-9V Peptide Vaccine
    773. TBC-CEA-Contaminated W/ BVDV Vaccine
    774. Telomerase Peptide Vaccine GV1001
    775. Telomerase-specific Type 5 Adenovirus OBP-301 Vaccine
    776. Telomerase: 540-548 Peptide Vaccine
    777. Tergenpumatucel-L Vaccine
    778. Tetanus peptide melanoma vaccine
    779. Tetraphenylethylene (TPE)-(alpha-S-GalNAc)3-P30-Tn-MUC1 Tripartite Vaccine
    780. Tetravalent RNA-lipoplex Cancer Vaccine
    781. TGFβ2 Antisense-GMCSF Gene Modified Autologous Tumor Cell Vaccine
    782. Therapeutic Breast/Ovarian/Prostate Peptide Cancer Vaccine DPX-0907
    783. TICE BCG
    784. TLR-9/GM Vaccine
    785. Tn(c)-KLH Conjugate Vaccine
    786. Total Tumor RNA-loaded Dendritic Cell Vaccine
    787. Transgenic Lymphocyte Immunization Vaccine
    788. TriAd Cancer Vaccine
    789. TriMixDC-MEL Vaccine
    790. Tripartite Branched Penetratin-Multiple Antigen Peptide (MAP)-MUC1 VNTR-Tetanus Toxoid Vaccine [AntpMAPMUC1tet]
    791. TRP-2: 180-188 Peptide Vaccine
    792. TRP1(0RF3):1-9 Peptide Vaccine
    793. Tumor antigen-sensitized DC vaccine
    794. Tumor Cell Derivative Vaccine
    795. Tumor Lysate-pulsed Dendritic Cell Vaccine
    796. Tumor Lysate/KLH Pulsed Dendritic Cell Vaccine
    797. TVI-Brain-1
    798. Tyrosinase-KLH Vaccine
    799. tyrosinase240–251S, 368-376D Vaccine
    800. Unconjugated Lymphoma Ig Id Vaccine
    801. Unconjugated Myeloma Ig Id Vaccine
    802. URLC10 Peptide Vaccine
    803. URLC10-CDCA1-KOC1 Multipeptide Vaccine
    804. URLC10-TTK-KOC1-VEGFR1-VEGFR2 Multipeptide Vaccine
    805. UV1 Telomerase Peptide Vaccine
    806. vaccinia melanoma cell lysates (VMCL) Vaccine
    807. Vaccinia Melanoma Oncolysates (VMO) Vaccine
    808. Vaccinia Virus DD-CDSR Vaccine
    809. Vaccinia-GM-CSF Vaccine
    810. Vaccinia-Tyrosinase Vaccine
    811. VCL-CB01 Vaccine
    812. VEGFR-2 DNA Vaccine VXM01
    813. VEGFR1-1084 Peptide Vaccine
    814. VEGFR2-169 Peptide Vaccine
    815. Verpasep Caltespen Vaccine
    816. VHL-42: 65-76(V74G) Peptide Vaccine
    817. VHL-59: 116-128 Peptide Vaccine
    818. VHL14 Peptide Vaccine
    819. VHL16 Peptide Vaccine
    820. VHL2 (Y12M) Peptide Vaccine
    821. Vi Capsular Polysaccharide Typhoid Vaccine
    822. Viagenpumatucel-L Vaccine
    823. VMCL
    824. Von Hippel-Lindau Peptide Vaccine
    825. Whole tumor cell-based leukemia vaccine
    826. WT1 124-138 Peptide Vaccine
    827. WT1 126-134 Peptide Vaccine
    828. WT1 235-243 Peptide Vaccine
    829. WT1 247-261 Peptide Vaccine
    830. WT1 Analog Peptide Vaccine
    831. WT1 Peptide Vaccine OCV-501
    832. WT1 Peptide Vaccine WT2725
    833. WT1 Trio Peptide Vaccine
    834. WT1-A10/AS01B Immunotherapeutic GSK2130579A Vaccine
    835. XBP1-US/XBP1-SP/CD138/CS1 Multipeptide Vaccine PVX-410
    836. Xenogeneic Tyrosinase DNA Vaccine
  4. References
I. General Information
1. Disease:
Cancer
2. Introduction
Cancer is a class of diseases in which a group of cells display uncontrolled growth (division beyond the normal limits), invasion (intrusion on and destruction of adjacent tissues), and sometimes metastasis (spread to other locations in the body via lymph or blood). These three malignant properties of cancers differentiate them from benign tumors, which are self-limited, and do not invade or metastasize. Most cancers form a tumor but some, like leukemia, do not. The branch of medicine concerned with the study, diagnosis, treatment, and prevention of cancer is oncology.

Cancer affects people at all ages with the risk for most types increasing with age. Cancer caused about 13% of all human deaths in 2007 (7.6 million). Cancers are caused by abnormalities in the genetic material of the transformed cells. These abnormalities may be due to the effects of carcinogens, such as tobacco smoke, radiation, chemicals, or infectious agents. Other cancer-promoting genetic abnormalities may randomly occur through errors in DNA replication, or are inherited, and thus present in all cells from birth. The heritability of cancers is usually affected by complex interactions between carcinogens and the host's genome.

Genetic abnormalities found in cancer typically affect two general classes of genes. Cancer-promoting oncogenes are typically activated in cancer cells, giving those cells new properties, such as hyperactive growth and division, protection against programmed cell death, loss of respect for normal tissue boundaries, and the ability to become established in diverse tissue environments. Tumor suppressor genes are then inactivated in cancer cells, resulting in the loss of normal functions in those cells, such as accurate DNA replication, control over the cell cycle, orientation and adhesion within tissues, and interaction with protective cells of the immune system.

Definitive diagnosis requires the histologic examination of a biopsy specimen, although the initial indication of malignancy can be symptomatic or radiographic imaging abnormalities. Most cancers can be treated and some forced into remission, depending on the specific type, location, and stage. Once diagnosed, cancer is usually treated with a combination of surgery, chemotherapy and radiotherapy. As research develops, treatments are becoming more specific for different varieties of cancer. There has been significant progress in the development of targeted therapy drugs that act specifically on detectable molecular abnormalities in certain tumors, and which minimize damage to normal cells. The prognosis of cancer patients is most influenced by the type of cancer, as well as the stage, or extent of the disease. In addition, histologic grading and the presence of specific molecular markers can also be useful in establishing prognosis, as well as in determining individual treatments (Wiki: Cancer).
Loading...
Loading Pathogen Genes...
Loading...
Loading Host Genes...
Loading...
Loading Vaccines...
Loading References...